Silence Therapeutics (SLN) Cash from Operations (QoQ) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.68% |
| Dec 31, 2025 | -58.35% |
| Sep 30, 2025 | 49.93% |
| Jun 30, 2025 | -76.98% |
| Mar 31, 2025 | 55.21% |
| Dec 31, 2024 | -7.60% |
| Sep 30, 2024 | -320.30% |
| Jun 30, 2024 | 33.54% |
| Mar 31, 2024 | 59.25% |
| Dec 31, 2023 | -263.56% |
| Sep 30, 2023 | 67.03% |
| Jun 30, 2023 | -101.11% |
| Mar 31, 2023 | 40.83% |
| Dec 31, 2022 | -41.90% |
| Sep 30, 2022 | -6.45% |
| Jun 30, 2022 | 46.02% |
| Mar 31, 2022 | -548.99% |
| Dec 31, 2021 | 56.24% |
| Sep 30, 2021 | -118.67% |
| Jun 30, 2021 | 318.19% |
| Mar 31, 2021 | -133.56% |
| Dec 31, 2020 | 10.84% |